Search results
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 14 hours agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 2 days agoBut the good news is that the newly dominant variants don’t appear more likely to cause...runny nose...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 22 hours agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 24 hours agoNovavax has become a safer buy of late COVID-19 vaccine maker Novavax can be ...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 5 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 4 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 5 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 4 days agoCompared with these separate vaccines, the combo shot produced "significantly higher immune...
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA TODAY via Yahoo News· 4 days agoThe...are set to be released in the fall, ahead of expected winter upticks in COVID-19 cases. "The FDA and CDC are working together...Team at USA TODAY.
Hospital-Acquired Infection Rates Remain High Post Pandemic
Medscape· 5 days agoA study across 120 US hospitals showed hospital-acquired gram-negative resistant infections were 13%...